市場調查報告書

乳癌篩檢的全球市場:2027年為止的預測,新型冠狀病毒感染疾病(COVID-19)的影響與全球市場分析

Breast Cancer Screening Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Test Type; End User, and Geography

出版商 The Insight Partners 商品編碼 935341
出版日期 內容資訊 英文 156 Pages
訂單完成後即時交付
價格
乳癌篩檢的全球市場:2027年為止的預測,新型冠狀病毒感染疾病(COVID-19)的影響與全球市場分析 Breast Cancer Screening Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Test Type; End User, and Geography
出版日期: 2020年04月23日內容資訊: 英文 156 Pages
簡介

全球乳癌篩檢市場在2019年估算為46億3,863萬美元,從2020年到2027年4.8%的年複合成長率繼續成長,達到62億925萬美元的規模。

本報告提供全球乳癌篩檢市場調查,提供市場概況和動態,各檢驗類型,各終端用戶,各地區的分析,COVID-19大流行病的影響,產業狀況,企業簡介等資訊。

目錄

第1章 簡介

  • 調查範圍
  • 調查報告的指導
  • 市場區隔

第2章 主要調查結果

  • 市場概要
  • 各地區市場
  • 主要國家的市場

第3章 調查手法

  • 調查範圍
  • 2次調查
  • 1次調查

第4章 市場的狀況

  • 市場概要
  • PEST分析
  • 專家的意見

第5章 市場力學

  • 成長促進因素
  • 成長阻礙因素
  • 市場機會
  • 今後趨勢
  • 影響分析

第6章 全球市場分析

  • 世界市場收益預測與分析
  • 各地區市場收益預測與分析
  • 主要企業的立場

第7章 市場分析:各檢驗類型

  • 概要
  • 市場佔有率:各檢驗類型
  • 血液標記檢驗
  • 影像檢查
  • 遺傳基因檢驗
  • 免疫組織化學檢驗

第8章 市場分析:各終端用戶

  • 概要
  • 市場佔有率:各終端用戶
  • 醫院
  • 診斷中心
  • 研究機關
  • 癌症研究所

第9章 各地區市場分析

  • 概要
  • 北美
  • 歐洲
  • 亞太地區
  • 中東·非洲
  • 中南美

第10章 COVID-19大流行病的影響

  • 北美
  • 歐洲
  • 亞太地區
  • 其他

第11章 產業情勢

  • 概要
  • 各公司的成長策略
  • 有機的發展
  • 無機的發展

第12章 主要企業的簡介

  • General Electric Company
  • Siemens Healthineers AG
  • Exact Sciences Corporation
  • Koninklijke Philips NV
  • Hologic,Inc.
  • BD
  • Myriad Genetics,Inc.
  • Oncocyte Corporation
  • Danaher
  • POC Medical Systems

第13章 附錄

目錄
Product Code: TIPRE00009796

The breast cancer screening was valued at US$ 4,638.63 million in 2019 and is projected to reach US$ 6,209.25 million by 2027; it is expected to grow at a CAGR of 4.8% from 2020 to 2027.

The growing prevalence of breast cancer and increasing investments in breast cancer management are the major factors driving the breast cancer screening market. However, the high cost of breast cancer screening is a chief factor limiting the market growth. Breast cancer is among the prime causes of deaths in the world, and it is profoundly affecting the quality of life. Thus, it acts as a burden on society if not diagnosed and treated on time. As per the estimations by the American Cancer Society, it is the most common type of cancer in the US as it caused morbidity in ~234,087 people, leading to 41,904 deaths in 2018. Further, ~276,480 new cases are expected in the country in 2020. As per the Globocan 2019 report, in Germany, the total number of breast cancer cases in 2018 was 71,888, which further led to ~19,376 deaths in that years. Further, as per the Globocan report, in 2018, there were ~367,900 new cases of breast cancer and 97,972 deaths due to the same in China. In India, NGOs, government agencies, and charity organizations are emphasizing on breast cancer awareness among population to promote early detection, provide comprehensive treatment module, and extend support for breast cancer management. As per the Globocan report estimation, in 2018, India reported ~162,468 new breast cancer cases, with 87,090 deaths due to the same.

The global breast cancer screening market has been segmented on the basis of test type and end user. The breast cancer screening market, by test type, has been segmented into blood marker tests, imaging test, genetic test, and immunohistochemistry test. The imaging test segment held the largest share of the market in 2019, and it is also anticipated to register the highest CAGR in the market during the forecast period. Based on end user, the breast cancer screening has been segmented into hospitals, diagnostic centers, cancer institutes, and research laboratories. The hospitals segment held the largest share of the market in 2019 and is expected to register fastest CAGR during the forecast period.

A few of the essential primary and secondary sources referred to during the preparation of the report are Food and Drug Administration, World Health Organization (WHO), Organization for Economic Co-operation and Development, and National Cancer Foundation.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the breast cancer screening market.

Highlights key business priorities in order to assist companies to realign their business strategies.

The key findings and recommendations highlight crucial progressive industry trends in the global breast cancer screening market, thereby allowing players across the value chain to develop effective long-term strategies.

Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

TABLE OF CONTENTS

1. Introduction

  • 1.1 Scope of the Study
  • 1.2 The Insight Partners Research Report Guidance
  • 1.3 Market Segmentation
    • 1.3.1 Global Breast Cancer Screening Market - By Test Type
    • 1.3.2 Global Breast Cancer Screening Market - By End User
    • 1.3.3 Global Breast Cancer Screening Market - By Geography

2. Breast Cancer Screening Market - Key Takeaways

  • 2.1 Global Breast Cancer Screening Market Overview
  • 2.2 Global Breast Cancer Screening Market, By Geography (US$ Million)
  • 2.3 Global Breast Cancer Screening Market- Leading Country Markets (US$ Million)

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Breast Cancer Screening - Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America - PEST Analysis
    • 4.2.2 Europe - PEST Analysis
    • 4.2.3 Asia Pacific - PEST Analysis
    • 4.2.4 Middle East and Africa (MEA) - PEST Analysis
    • 4.2.5 South and Central America (SCAM) - PEST Analysis
  • 4.3 Expert Opinion

5. Breast Cancer Screening- Key Market Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Globally Growing Breast Cancer Prevalence
    • 5.1.2 Increasing Investments in Breast Cancer Management
  • 5.2 Key Market Restraints
    • 5.2.1 High Cost of Breast Cancer Screening
  • 5.3 Key Market Opportunities
    • 5.3.1 Emerging Markets in Developing Countries
  • 5.4 Future Trends
    • 5.4.1 Consistent Launch of New Screening Products
  • 5.5 Impact Analysis

6. Breast Cancer Screening Market - Global Analysis

  • 6.1 Global Breast Cancer Screening Market Revenue Forecast and Analysis
  • 6.2 Global Breast cancer screening Market, By Geography - Forecast and Analysis
  • 6.3 Market Positioning of Key Players

7. Breast Cancer Screening Market Analysis - By Test Type

  • 7.1 Overview
  • 7.2 Breast Cancer Screening Market Revenue Share, by Test Type (2019 and 2027)
  • 7.3 Blood Marker Test
    • 7.3.1 Overview
    • 7.3.2 Blood Marker Tests:Breast Cancer Screening Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.5 Imaging Test
    • 7.5.1 Overview
    • 7.5.2 Imaging Test: Breast Cancer Screening Market- Revenue and Forecast to 2027 (US$ Million)
  • 7.6 Genetic Test
    • 7.6.1 Overview
    • 7.6.2 Genetic Test: Breast Cancer Screening Market - Revenue and Forecast to 2027 (US$ Million)
  • 7.7 Immunohistochemistry Test
    • 7.7.1 Overview
    • 7.7.2 Immunohistochemistry Test: Breast Cancer Screening Market - Revenue and Forecast to 2027 (US$ Million)

8. Breast Cancer Screening Market - By End User

  • 8.1 Overview
  • 8.2 Breast Cancer Screening Market, by End-User, 2019 and 2027 (%)
  • 8.3 Hospitals
    • 8.3.1 Overview
    • 8.3.2 Hospitals: Breast Cancer Screening Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.4 Diagnostics Centers
    • 8.4.1 Overview
    • 8.4.2 Diagnostic Centers: Breast Cancer Screening Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.5 Research Laboratories
    • 8.5.1 Overview
  • 8.6 Research Laboratories: Breast Cancer Screening Market - Revenue and Forecast to 2027 (US$ Million)
  • 8.7 Cancer Institutes
    • 8.7.1 Overview
  • 8.8 Cancer Institutes: Breast Cancer Screening Market - Revenue and Forecast to 2027 (US$ Million)

9. Breast Cancer Screening Market - Geographic Analysis

  • 9.1 North America: Breast Cancer Screening Market
    • 9.1.1 Overview
    • 9.1.2 North America: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
    • 9.1.3 North America: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
    • 9.1.4 North America: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
    • 9.1.5 North America: Breast Cancer Screening Market, by Country, 2019 & 2027 (%)
    • 9.1.6 US: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.6.1 US: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.6.2 US: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
      • 9.1.6.3 US: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
    • 9.1.7 Canada: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.7.1 Canada: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.7.2 Canada: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
      • 9.1.7.3 Canada: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
    • 9.1.8 Mexico: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.8.1 Mexico: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
      • 9.1.8.2 Mexico: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
      • 9.1.8.3 Mexico: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
  • 9.2 Europe: Breast Cancer Screening Market
    • 9.2.1 Overview
    • 9.2.2 Europe: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
    • 9.2.3 Europe: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
    • 9.2.4 Europe: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
    • 9.2.5 Europe: Breast Cancer Screening Market, by Country, 2018 & 2027 (%)
    • 9.2.6 Germany: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.6.1 Germany: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.6.2 Germany: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
      • 9.2.6.3 Germany: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
    • 9.2.7 UK: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.7.1 UK: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.7.2 UK: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
      • 9.2.7.3 UK: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
    • 9.2.8 France: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.8.1 France: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.8.2 France: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
      • 9.2.8.3 France: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
    • 9.2.9 Spain: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.9.1 Spain: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.9.2 Spain: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
      • 9.2.9.3 Spain: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
    • 9.2.10 Italy: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.10.1 Italy: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
      • 9.2.10.2 Italy: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
      • 9.2.10.3 Italy: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
  • 9.3 Asia Pacific: Breast Cancer Screening Market
    • 9.3.1 Overview
    • 9.3.2 Asia Pacific: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
    • 9.3.3 Asia Pacific: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
    • 9.3.4 Asia Pacific: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
    • 9.3.5 Asia Pacific: Breast Cancer Screening Market, by Country, 2018 & 2027 (%)
    • 9.3.6 China: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.6.1 China: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.6.2 China: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
      • 9.3.6.3 China: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
    • 9.3.7 Japan: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.7.1 Japan: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.7.2 Japan: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
      • 9.3.7.3 Japan: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
    • 9.3.8 India: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.8.1 India: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.8.2 India: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
      • 9.3.8.3 India: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
    • 9.3.9 South Korea: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.9.1 South Korea: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.9.2 South Korea: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
      • 9.3.9.3 South Korea: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
    • 9.3.10 Australia: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.10.1 Australia: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
      • 9.3.10.2 Australia: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
      • 9.3.10.3 Australia: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
  • 9.4 Middle East & Africa: Breast Cancer Screening Market
    • 9.4.1 Overview
    • 9.4.2 Middle East & Africa: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
    • 9.4.3 Middle East & Africa: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
    • 9.4.4 Middle East & Africa: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
    • 9.4.5 Middle East & Africa: Breast Cancer Screening Market Share by Country - 2019 & 2027, (%)
    • 9.4.6 Saudi Arabia: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.6.1 Saudi Arabia: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.6.2 Saudi Arabia: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
      • 9.4.6.3 Saudi Arabia: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
    • 9.4.7 UAE: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.7.1 UAE: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.7.2 UAE: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
      • 9.4.7.3 UAE: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
    • 9.4.8 South Africa: Breast Cancer Screening Market - Revenue and Forecast to 2027 (US$ Million)
      • 9.4.8.1 South Africa: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
      • 9.4.8.2 South Africa: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
      • 9.4.8.3 South Africa: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
  • 9.5 South and Central America: Breast Cancer Screening Market
    • 9.5.1 Overview
    • 9.5.2 South and Central America: Breast Cancer Screening Market - Revenue and Forecast to 2027 (US$ Million)
    • 9.5.3 South and Central America: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
    • 9.5.4 South and Central America: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
    • 9.5.5 South and Central America: Breast Cancer Screening Market, by Country, 2018 & 2027 (%)
    • 9.5.6 Brazil: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
      • 9.5.6.1 Brazil: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
      • 9.5.6.2 Brazil: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
      • 9.5.6.3 Brazil: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)
    • 9.5.7 Argentina: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
      • 9.5.7.1 Argentina: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
      • 9.5.7.2 Argentina: Breast Cancer Screening Market, by Test Type, 2018-2027 (USD Million)
      • 9.5.7.3 Argentina: Breast Cancer Screening Market, by End User, 2018-2027 (USD Million)

10. Impact Of COVID-19 Pandemic On Global Breast Cancer Screening Market

  • 10.1 North America: Impact Assessment of COVID-19 Pandemic
  • 10.2 Europe: Impact Assessment Of COVID-19 Pandemic
  • 10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
  • 10.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

11. Breast Cancer Screening Market -Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in The Breast Cancer Screening Market, 2016-2020
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Breast Cancer Screening Market - Key Company Profiles

  • 12.1 General Electric Company
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Siemens Healthineers AG
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Exact Sciences Corporation
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Koninklijke Philips N.V.
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Hologic, Inc.
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 BD
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Myriad Genetics, Inc.
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Oncocyte Corporation
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Danaher
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 POC Medical Systems
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About the Insight Partners
  • 13.2 Glossary of Terms

LIST OF TABLES

  • Table 1. North America Breast Cancer Screening Market, by Test Type- Revenue and Forecast to 2027 (USD Million)
  • Table 2. North America Breast Cancer Screening Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 3. US Breast Cancer Screening Market, by Test Type - Revenue and Forecast to 2027 (USD Million)
  • Table 4. US Breast Cancer Screening Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 5. Canada Breast Cancer Screening Market, by Test Type - Revenue and Forecast to 2027 (USD Million)
  • Table 6. Canada Breast Cancer Screening Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 7. Mexico Breast Cancer Screening Market, by Test Type - Revenue and Forecast to 2027 (USD Million)
  • Table 8. Mexico Breast Cancer Screening Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 9. Europe Breast Cancer Screening Market, by Test Type- Revenue and Forecast to 2027 (USD Million)
  • Table 10. Europe Breast Cancer Screening Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 11. Germany Breast Cancer Screening Market, by Test Type - Revenue and Forecast to 2027 (USD Million)
  • Table 12. Germany Breast Cancer Screening Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 13. UK Breast Cancer Screening Market, by Test Type - Revenue and Forecast to 2027 (USD Million)
  • Table 14. UK Breast Cancer Screening Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 15. France Breast Cancer Screening Market, by Test Type - Revenue and Forecast to 2027 (USD Million)
  • Table 16. France Breast Cancer Screening Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 17. Spain Breast Cancer Screening Market, by Test Type - Revenue and Forecast to 2027 (USD Million)
  • Table 18. Spain Breast Cancer Screening Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 19. Italy Breast Cancer Screening Market, by Test Type - Revenue and Forecast to 2027 (USD Million)
  • Table 20. Italy Breast Cancer Screening Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 21. Asia Pacific Breast Cancer Screening Market, by Test Type- Revenue and Forecast to 2027 (USD Million)
  • Table 22. Asia Pacific Breast Cancer Screening Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 23. China Breast Cancer Screening Market, by Test Type - Revenue and Forecast to 2027 (USD Million)
  • Table 24. China Breast Cancer Screening Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 25. Japan Breast Cancer Screening Market, by Test Type - Revenue and Forecast to 2027 (USD Million)
  • Table 26. Japan Breast Cancer Screening Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 27. IndiaBreast Cancer Screening Market, by Test Type - Revenue and Forecast to 2027 (USD Million)
  • Table 28. IndiaBreast Cancer Screening Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 29. South Korea Breast Cancer Screening Market, by Test Type - Revenue and Forecast to 2027 (USD Million)
  • Table 30. South Korea Breast Cancer Screening Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 31. Australia Breast Cancer Screening Market, by Test Type - Revenue and Forecast to 2027 (USD Million)
  • Table 32. Australia Breast Cancer Screening Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 33. Middle East & Africa Breast Cancer Screening Market, by Test Type- Revenue and Forecast to 2027 (USD Million)
  • Table 34. Middle East & Africa Breast Cancer Screening Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 35. Saudi Arabia Breast Cancer Screening Market, by Test Type - Revenue and Forecast to 2027 (USD Million)
  • Table 36. Saudi Arabia Breast Cancer Screening Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 37. UAE Breast Cancer Screening Market, by Test Type - Revenue and Forecast to 2027 (USD Million)
  • Table 38. UAE Breast Cancer Screening Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 39. South Africa Breast Cancer Screening Market, by Test Type - Revenue and Forecast to 2027 (USD Million)
  • Table 40. South Africa Breast Cancer Screening Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 41. South and Central America Breast Cancer Screening Market, by Test Type- Revenue and Forecast to 2027 (USD Million)
  • Table 42. South and Central America Breast Cancer Screening Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 43. Brazil Breast Cancer Screening Market, by Test Type - Revenue and Forecast to 2027 (USD Million)
  • Table 44. Brazil Breast Cancer Screening Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 45. Argentina Breast Cancer Screening Market, by Test Type - Revenue and Forecast to 2027 (USD Million)
  • Table 46. Argentina Breast Cancer Screening Market, by End User - Revenue and Forecast to 2027 (USD Million)
  • Table 47. Recent Inorganic Growth Strategies In The Breast Cancer Screening Market
  • Table 48. Recent Organic Growth Strategies In The Breast Cancer Screening Market
  • Table 49. Glossary of Terms, Breast Cancer Screening Market

LIST OF FIGURES

  • Figure 1. Breast Cancer Screening Market Segmentation
  • Figure 2. Breast Cancer Screening Segmentation, By Region
  • Figure 3. Imaging Tests Held Largest Share of Breast Cancer Screening Market
  • Figure 4. Asia Pacific to Register Remarkable CAGR in Market During Forecast Period
  • Figure 5. North America PEST Analysis
  • Figure 6. Europe PEST Analysis
  • Figure 7. Asia Pacific PEST Analysis
  • Figure 8. Middle East and Africa (MEA) PEST Analysis
  • Figure 9. South and Central America (SCAM) PEST Analysis
  • Figure 10. Breast Cancer Screening Market Impact Analysis Of Driver And Restraints
  • Figure 11. Global Breast Cancer Screening Market - Revenue Forecast and Analysis - 2019- 2027
  • Figure 12. Global Breast cancer screening Market - By Geography Forecast And Analysis - 2019- 2027
  • Figure 13. Market Positioning Of Key Players In Global Breast cancer screening Market
  • Figure 14. Breast Cancer Screening Market Revenue Share, by Test Type (2019 and 2027)
  • Figure 15. Blood Marker Tests: Breast Cancer Screening Market- Revenue and Forecast to 2027 (US$ Million)
  • Figure 16. Imaging Test: Breast Cancer Screening Market- Revenue and Forecast to 2027 (US$ Million)
  • Figure 17. Genetic Test: Breast Cancer Screening Market- Revenue and Forecast to 2027 (US$ Million)
  • Figure 18. Immunohistochemistry Test: Breast Cancer Screening Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 19. Breast Cancer Screening Market, by End-User, 2019 and 2027 (%)
  • Figure 20. Hospitals: Breast Cancer Screening Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 21. Diagnostic Centers: Breast Cancer Screening Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 22. Research Laboratories: Breast Cancer Screening Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 23. Cancer Institutes: Breast Cancer Screening Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 24. North America: Breast Cancer Screening Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 25. North America Breast Cancer Screening Market Revenue and Forecast to 2027 (USD Million)
  • Figure 26. North America: Breast Cancer Screening Market, by Country, 2019 & 2027 (%)
  • Figure 27. US: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 28. Canada: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 29. Mexico: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 30. Europe: Breast Cancer Screening Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 31. Europe Breast Cancer Screening Market Revenue and Forecast to 2027 (USD Million)
  • Figure 32. Europe: Breast Cancer Screening Market, by Country, 2018 & 2027 (%)
  • Figure 33. Germany: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 34. UK: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 35. France: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 36. Spain: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 37. Italy: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 38. Asia Pacific: Breast Cancer Screening Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 39. Asia Pacific Breast Cancer Screening Market Revenue and Forecast to 2027 (USD Million)
  • Figure 40. China: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 41. Japan: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 42. India: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 43. South Korea: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 44. Australia: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 45. Middle East & Africa: Breast Cancer Screening Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 46. Middle East & Africa Breast Cancer Screening Market Revenue and Forecast to 2027 (USD Million)
  • Figure 47. Middle East & Africa: Breast Cancer Screening Market Share by Country - 2019 & 2027, (%)
  • Figure 48. Saudi Arabia: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 49. UAE: Breast Cancer Screening Market - Revenue and Forecast to 2027 (US$ Million)
  • Figure 50. South Africa: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 51. South and Central America: Breast Cancer Screening Market, by Key Country - Revenue (2019) (USD Million)
  • Figure 52. South and Central America Breast Cancer Screening Market Revenue and Forecast to 2027 (USD Million)
  • Figure 53. South and Central America: Breast Cancer Screening Market, by Country, 2018 & 2027 (%)
  • Figure 54. Brazil: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 55. Argentina: Breast Cancer Screening Market - Revenue and Forecast to 2027 (USD Million)
  • Figure 56. Impact of COVID-19 Pandemic In North American Country Markets
  • Figure 57. Impact of COVID-19 Pandemic In European Country Markets
  • Figure 58. Impact of COVID-19 Pandemic In Asia Pacific Country Markets
  • Figure 59. Impact Of COVID-19 Pandemic In Rest of the World Countries Market
  • Figure 60. Growth Strategies in TheBreast Cancer Screening Market, 2016-2020